Several studies have shown that a number of Bifidobacterium strains have antibacterial activity against various pathogens, including Escherichia coli, Salmonella typhi [7], Streptococcus mutans [8], Propionibacterium acnes [9], and Listeria monocytogenes Moreover, some studies have reported that Bifidobacterium strains can be used against multidrug-resistant pathogens. One study showed that probiotics, including some Lactobacillus strains, could inhibit or remove the biofilm formed by multidrug-resistant E. coli; amongst all the tested probiotics, B. longum showed the strongest inhibition against the biofilm formed by E. coli IC2
No takes yet. Share an insight, caveat, or question.
Lim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: